FLUENT Corp. (CSE: FNT.U; OTCQB: CNTMF) on Friday said it has entered into a definitive agreement to sell its Texas business, including cultivation, manufacturing, delivery and retail operations, to Legacy Therapeutics for $30 million. Under the deal, $25 million will be paid at closing, with two additional $2.5 million payments due on the first and […]
Source link
You May Also Like
strain roundup
Breaking News
Federal Drug Policy, April 2026: The Operative Architecture of Cannabis Rescheduling, the Psychedelic Therapeutic Acceleration Directive, and the Road to June 29 RN...
cannabis business
As the end of November approaches you can feel the buzz amongst cannabis industry circles about the yearly pilgrimage we all make to Las...
cannabis events
It’s been a couple weeks since MJBizCon 2024 concluded, but many of us are still riding high from the energy and hustle of this...